🔥🔥 Don’t Miss Out on Our End of Autumn Sale. If you have any questions, feel free to click the bottom right corner to contact our customer service..

Concat us[email protected]
Shopping Cart

No products in the cart.

🔍
BS ISO 29943-1:2017

BS ISO 29943-1:2017

$198.66

Condoms. Guidance on clinical studies – Male condoms, clinical function studies based on self-reports

Published By Publication Date Number of Pages
BSI 2017 52
PDF Format Searchable Printable Preview Now
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

This document is intended to help in the design, execution, analysis and interpretation of clinical function studies conducted in accordance with the requirements of ISO 23409 for male synthetic condoms.

These clinical studies compare the performance of a new male condom to an established male condom during vaginal intercourse (not anal intercourse). In particular, these studies are designed to assess acute failure events during use (i.e. clinical slippage and clinical breakage).

This document also provides direction on the analysis of data when the study is completed, as well as interpretation of these results by manufacturers and regulatory bodies.

Certain clinical trial elements are not addressed in this document, including compensation, confidentiality of individuals and their records, use of local ethics committees, etc. These and many other clinical trial design issues are covered in greater detail in ISO 14155 .

PDF Catalog

PDF Pages PDF Title
2 National foreword
7 Foreword
8 Introduction
9 1 Scope
2 Normative references
3 Terms and definitions
10 4 Pilot clinical studies
11 5 Clinical validation investigation
5.1 Objectives of clinical validation investigation
5.2 Outcome measures
5.3 Study subjects
5.3.1 General
5.3.2 Enrolment of study subjects
13 5.4 Informed consent
5.5 Test and control condoms
5.5.1 General
5.5.2 Test condom
14 5.5.3 Control condom made from natural rubber latex
5.5.4 Expiration date of control condom
5.5.5 Storage conditions
5.5.6 Trial duration exceeds 1 year
5.5.7 Sampling of control condoms for bench testing
5.6 Randomization
15 5.7 Allocation concealment and study masking
5.8 Use of additional lubricant
5.9 Instructions and interactions with study couples
16 5.10 Interviews and data collection
5.10.1 Schedule for interviews and condom distribution
5.10.2 Enrolment interview
5.10.3 Individual condom use CRF
17 5.10.4 Mid-study CRF, crossover trial
5.10.5 Compiling data from CRFs
18 5.11 Data integrity
5.11.1 General
5.11.2 Interactive voice response systems (IVRS)
5.11.3 Mail-in and web-based data reporting
19 5.11.4 Web-based data collection systems and additional suggestions
5.12 Control of distribution chain
20 5.13 Analysis of returned condoms
5.14 Other methodological details
5.15 Statistical analysis plan
5.15.1 General
21 5.15.2 Primary study hypothesis
5.15.3 Secondary study hypotheses
5.15.4 Study design
22 5.15.5 Statistical analysis
5.15.6 Additional statistical comments and concerns
23 5.16 Clinical study results: Review and interpretation
5.16.1 General
5.16.2 Total clinical failure rates for control condom
5.16.3 Non-inferiority
5.16.4 Superiority
5.16.5 Safety (adverse events)
24 5.16.6 What happens if one is unable to conclude non-inferiority?
25 Annex A (informative) Formula for power calculation
26 Annex B (informative) Pilot clinical investigation (sample outline)
28 Annex C (informative) Time and events schedule for individual study subject (sample)
29 Annex D (informative) CRF — Study entry (sample)
32 Annex E (informative) CRF — Mid-study (sample)
33 Annex F (informative) CRF — Individual condom use (sample)
40 Annex G (informative) CRF — Adverse event (sample)
42 Annex H (informative) Protocol for evaluation of returned used condoms
49 Bibliography

Related products

BS ISO 29943-1:2017
$198.66